Skip to main content
. 1998 Mar 3;95(5):2452–2457. doi: 10.1073/pnas.95.5.2452

Figure 4.

Figure 4

Reporter assays of the IL-15 promoter construct h15/sAP in HTLV-I-infected T cell lines and Jurkat (resting and activated) cells, as well as two Jurkat Tax transfectants, JPX-m and JPX-9. Ten micrograms of the h15/sAP construct were cotransfected with 5 μg of the β-galactoside plasmid used to normalize the transformation efficiency. The average of the results of three reporter assays was used to generate each graph.